Search research articles
Contact Us
Filters
Showing results (331-340 of 347) with videos related to
Page
of 35
Sort By:
Neurology
|
February 1, 1996
Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway
C F Lippa, A M Saunders, T W Smith, et al.
Annals of Neurology
|
November 18, 1998
Association between bleomycin hydrolase and Alzheimer's disease in caucasians
L A Farrer, C R Abraham, J L Haines, et al.
Annals of Neurology
|
August 1, 1996
Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism
Y Xia, H A Rohan de Silva, B L Rosi, et al.
American Journal of Human Genetics
|
June 28, 2000
SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease
E R Martin, E H Lai, J R Gilbert, et al.
Brain Research. Molecular Brain Research
|
May 29, 1998
Amyloid-beta-protein isoforms in brain of subjects with PS1-linked, beta APP-linked and sporadic Alzheimer disease
A Tamaoka, P E Fraser, K Ishii, et al.
JAMA
|
March 12, 1997
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective
S G Post, P J Whitehouse, R H Binstock, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 17, 2000
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
G W Small, L M Ercoli, D H Silverman, et al.
Nature Genetics
|
August 1, 1996
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group
J L Haines, M Ter-Minassian, A Bazyk, et al.
Neurogenetics
|
December 14, 1999
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease
W K Scott, L H Yamaoka, J M Stajich, et al.
Nature Genetics
|
May 13, 1999
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease
E A Rogaeva, S Premkumar, J Grubber, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 347) with videos related to
Sort By:
Page
of 35
Neurology
|
February 1, 1996
Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway
C F Lippa, A M Saunders, T W Smith, et al.
Annals of Neurology
|
November 18, 1998
Association between bleomycin hydrolase and Alzheimer's disease in caucasians
L A Farrer, C R Abraham, J L Haines, et al.
Annals of Neurology
|
August 1, 1996
Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism
Y Xia, H A Rohan de Silva, B L Rosi, et al.
American Journal of Human Genetics
|
June 28, 2000
SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease
E R Martin, E H Lai, J R Gilbert, et al.
Brain Research. Molecular Brain Research
|
May 29, 1998
Amyloid-beta-protein isoforms in brain of subjects with PS1-linked, beta APP-linked and sporadic Alzheimer disease
A Tamaoka, P E Fraser, K Ishii, et al.
JAMA
|
March 12, 1997
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective
S G Post, P J Whitehouse, R H Binstock, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 17, 2000
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
G W Small, L M Ercoli, D H Silverman, et al.
Nature Genetics
|
August 1, 1996
A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group
J L Haines, M Ter-Minassian, A Bazyk, et al.
Neurogenetics
|
December 14, 1999
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease
W K Scott, L H Yamaoka, J M Stajich, et al.
Nature Genetics
|
May 13, 1999
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease
E A Rogaeva, S Premkumar, J Grubber, et al.
Page
of 35